1. Home
  2. AIXC vs LSTA Comparison

AIXC vs LSTA Comparison

Compare AIXC & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIXC

AIxCrypto Holdings Inc.

HOLD

Current Price

$0.79

Market Cap

27.9M

Sector

Health Care

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$1.76

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIXC
LSTA
Founded
1996
1980
Country
United States
United States
Employees
10
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Misc Health and Biotechnology Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
28.9M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
AIXC
LSTA
Price
$0.79
$1.76
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
35.6K
65.8K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
N/A
N/A
Revenue
N/A
$35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$0.68
$1.81
52 Week High
$2.98
$5.07

Technical Indicators

Market Signals
Indicator
AIXC
LSTA
Relative Strength Index (RSI) 39.11 19.52
Support Level N/A N/A
Resistance Level $1.45 $2.19
Average True Range (ATR) 0.11 0.22
MACD -0.01 -0.18
Stochastic Oscillator 35.42 1.40

Price Performance

Historical Comparison
AIXC
LSTA

About AIXC AIxCrypto Holdings Inc.

AIxCrypto Holdings Inc is a technology infrastructure company focused on the convergence of artificial intelligence and blockchain-based programmable systems. The Company develops software platforms and programmable infrastructure designed to facilitate the tokenization of real-world assets (RWA) and the deployment of Embodied Artificial Intelligence (EAI) in commercial environments. Its mission is to serve as the regulated, programmable infrastructure layer connecting traditional capital markets with on-chain systems and AI-enabled commercial systems.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: